A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer. | Drug Discovery And ...

Don’t wait for the first symptom. Start regular colorectal cancer screening at 45 years old to stay proactive about your ...

Colon cancer, also known as colorectal cancer, is one of the most frequent and aggressive cancers. According to the WHO, it ...

A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.

Survival rates also varied significantly by stage. In the combined analysis for men and women without metastasis, the ...

A new study from UC San Diego in La Jolla offers evidence that the class of weight-loss drugs behind Ozempic, Wegovy and Mounjaro may do more than regulate blood sugar and weight — it might improve ...

BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...

The five-year survival rate for male and female patients in Japan who were diagnosed with pancreatic cancer between 2012 and 2015 came to 10.7 pct and 10.2 pct, respectively, the lowest among all ...

Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

Artios Pharma, a Babraham-based biopharma company realising the therapeutic power of targeting the DNA damage response in ...